MODIFICATION TO MAMMAPRINT— 510(k) K081092

Substantially Equivalent

Agendia

FDA 510(k) clearance K081092 for MODIFICATION TO MAMMAPRINT, Substantially Equivalent on 2009-12-11. Applicant: Agendia.

Clearance details

Applicant: Agendia
Product code: Code NYI
Advisory panel: Immunology
Date received: 2008-04-17
Decision date: 2009-12-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Amsterdam, NL

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.